Inhibition of pancreatic secretion by enkephalin and morphine in dogs.
The nature and extent of enkephalin- and morphine-induced inhibition of pancreatic bicarbonate and protein secretion were studied in dogs with chronic pancreatic fistulae after administering exogenous secretin or octapeptide of cholecystokinin and stimulants for the endogenous release of these hormones. Enkephalin and morphine competitively inhibited the pancreatic bicarbonate secretion induced either by exogenous secretin or duodenal acidification. This inhibition was partially reversed by naloxone, an opiate antagonist. Opiate substance also profoundly inhibited pancreatic protein response to octapeptide of cholecystokinin and to various stimulants of endogenous cholecystokinin release. We conclude that enkephalin and morphine strongly inhibit the pancreatic responses to exogenous and endogenous stimulants by a mechanism involving separate opiate receptors.
D000818:Animals; D001639:Bicarbonates / Q000378:metabolism; D002766:Cholecystokinin; D002908:Chronic Disease; D003864:Depression, Chemical; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004386:Duodenum / Q000378:metabolism; D004723:Endorphins / Q000494:pharmacology*; D004745:Enkephalins / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D010455:Peptides; D011506:Proteins / Q000378:metabolism; D011957:Receptors, Opioid; D012633:Secretin
D001639:Bicarbonates; D004723:Endorphins; D004745:Enkephalins; D010455:Peptides; D011506:Proteins; D011957:Receptors, Opioid; D012633:Secretin; D009270:Naloxone; D009020:Morphine; D002766:Cholecystokinin